Current status: 831 hESC lines, 3142 hiPSC lines, and 97 clinical studies, and 409 certificates
Monthly statistic from May 1, 2022
Posted on May 1, 2022
| total lines | 3973 |
| hESC lines | 831 |
| hiPSC lines | 3142 |
| derivation countries | 43 |
| projects | 230 |
| providers | 716 |
| clinical studies | 97 |
| subclones | 1518 |
| certificates | 409 |
| cell line certificates | 295 |
| project certificates | 114 |